Alternative Vaccine Strategy Shows Promise In Prostate Cancer Patients
Sunday, August 24, 2008 - 20:21
in Health & Medicine
New research indicates that giving patients a continuous low dose of an immune system booster, a method known as metronomic dosing, as part of a therapeutic prostate cancer vaccine strategy is safe and produces similar immune responses and fewer side effects than the more common dosing method, which is not well tolerated by many patients.